Literature DB >> 24865698

Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

Keitaro Sofue1, Masakatsu Tsurusaki, Takamichi Murakami, Shunsuke Onoe, Hiroyuki Tokue, Kentaro Shibamoto, Yasuaki Arai, Kazuro Sugimura.   

Abstract

OBJECTIVES: To compare diagnostic performance in the detection of colorectal liver metastases between 64-detector-row contrast-enhanced CT (CE-CT) alone and the combination of CE-CT and gadoxetic acid-enhanced MRI (EOB-MRI) at 3.0T, and to assess whether EOB-MRI in addition to CE-CT results in a change to initially planned operative strategy.
METHODS: A total of 39 patients (27 men, mean age 65 years) with 85 histopathologically confirmed liver metastases were included. At EOB-MRI, unenhanced (T1- and T2-weighted), dynamic, and hepatocyte-phase images were obtained. At CE-CT, four-phase dynamic contrast-enhanced images were obtained. One on-site reader and three off-site readers independently reviewed both CE-CT alone and the combination of CE-CT and EOB-MRI. Sensitivity, positive predictive value, and alternative free-response receiver operating characteristic (AFROC) method were calculated. Differences in therapeutic strategy before and after the EOB-MRI examination were also evaluated.
RESULTS: Sensitivity and area under the AFROC curve with the combination of CE-CT and EOB-MRI were significantly superior to those with CE-CT alone. Changes in surgical therapy were documented in 13 of 39 patients.
CONCLUSIONS: The combination of CE-CT and EOB-MRI may provide better diagnostic performance than CE-CT alone for the detection of colorectal liver metastases, and EOB-MRI in addition to CE-CT resulted in changes to the planned operative strategy in one-third of the patients. KEY POINTS: • Accurate preoperative imaging is essential for surgical planning and successful hepatic resection. • Combination of CE-CT and EOB-MRI is useful to detect colorectal liver metastases. • EOB-MRI combined with CE-CT contributes to determine the correct therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865698     DOI: 10.1007/s00330-014-3233-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

Review 2.  3.0-T MR imaging of the abdomen: comparison with 1.5 T.

Authors:  Kevin J Chang; Ihab R Kamel; Katarzyna J Macura; David A Bluemke
Journal:  Radiographics       Date:  2008 Nov-Dec       Impact factor: 5.333

3.  Preoperative imaging for hepatic resection of colorectal cancer metastasis.

Authors:  Timothy L Frankel; Richard Kinh Gian; William R Jarnagin
Journal:  J Gastrointest Oncol       Date:  2012-03

4.  Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.

Authors:  Hyo Jung Seo; Myeong-Jin Kim; Jong Doo Lee; Woo-Suk Chung; Yeo-Eun Kim
Journal:  Invest Radiol       Date:  2011-09       Impact factor: 6.016

5.  Epidemiology and management of liver metastases from colorectal cancer.

Authors:  Sylvain Manfredi; Côme Lepage; Cyril Hatem; Olivier Coatmeur; Jean Faivre; Anne-Marie Bouvier
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

6.  Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).

Authors:  Young Kon Kim; Min Woo Lee; Won Jae Lee; Seong Hyun Kim; Hyunchul Rhim; Jae Hoon Lim; Dongil Choi; Young-sun Kim; Kyung Mi Jang; Soon Jin Lee; Hyo Keun Lim
Journal:  Invest Radiol       Date:  2012-03       Impact factor: 6.016

7.  High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T.

Authors:  Marcus M von Falkenhausen; Götz Lutterbey; Nuschin Morakkabati-Spitz; Oliver Walter; Jürgen Gieseke; Renate Blömer; Winfried A Willinek; Hans H Schild; Christiane K Kuhl
Journal:  Radiology       Date:  2006-08-14       Impact factor: 11.105

Review 8.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

9.  Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.

Authors:  M Scharitzer; A Ba-Ssalamah; H Ringl; C Kölblinger; T Grünberger; M Weber; W Schima
Journal:  Eur Radiol       Date:  2013-03-22       Impact factor: 5.315

10.  Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Authors:  Renate Hammerstingl; Alexander Huppertz; Josy Breuer; Thomas Balzer; Anthony Blakeborough; Rick Carter; Lluis Castells Fusté; Gertraud Heinz-Peer; Werner Judmaier; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Müller; Koenraad Mortelè; Peter Reimer; Maximilian F Reiser; Philip J Robinson; Kohkan Shamsi; Michael Strotzer; Matthias Taupitz; Bernd Tombach; Gianluca Valeri; Bernhard E van Beers; Thomas J Vogl
Journal:  Eur Radiol       Date:  2007-12-06       Impact factor: 5.315

View more
  13 in total

1.  3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?

Authors:  Rossano Girometti
Journal:  World J Hepatol       Date:  2015-07-28

2.  Simultaneous resection for colorectal cancer and synchronous liver metastases.

Authors:  Yasuyuki Fukami; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Shunsuke Onoe; Masatoshi Isogai
Journal:  Surg Today       Date:  2015-05-26       Impact factor: 2.549

3.  Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.

Authors:  Nobuyuki Asato; Masakatsu Tsurusaki; Keitaro Sofue; Yoko Hieda; Takashi Katsube; Kazuhiro Kitajima; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2017-03-01       Impact factor: 2.374

4.  Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.

Authors:  He-Yue Liang; Ya-Qin Huang; Zhao-Xia Yang; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Eur Radiol       Date:  2015-10-22       Impact factor: 5.315

5.  The role of MRI using liver-specific contrast agent in the assessment of focal liver lesion.

Authors:  Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2014 Sep-Oct

6.  Application of computed tomography virtual noncontrast spectral imaging in evaluation of hepatic metastases: a preliminary study.

Authors:  Shi-Feng Tian; Ai-Lian Liu; Jing-Hong Liu; Mei-Yu Sun; He-Qing Wang; Yi-Jun Liu
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

7.  Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.

Authors:  Christoph J Zech; Nahila Justo; Andrea Lang; Ahmed Ba-Ssalamah; Myeong-Jin Kim; Harald Rinde; Eduard Jonas
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

8.  Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis.

Authors:  Dahye Lee; Eun-Suk Cho; Dae Jung Kim; Joo Hee Kim; Jeong-Sik Yu; Jae-Joon Chung
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

9.  Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with ¹⁸F-FDG PET/CT.

Authors:  Ji-Won Oh; Soon Nam Oh; Joon Il Choi; Moon Hyung Choi; Ie Ryung Yoo; Myung Ah Lee; Young-Kyung Yoo; Seong Taek Oh
Journal:  Biomed Res Int       Date:  2016-02-28       Impact factor: 3.411

10.  Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.

Authors:  Tomasz K Nowicki; Karolina Markiet; Ewa Izycka-Swieszewska; Katarzyna Dziadziuszko; Michal Studniarek; Edyta Szurowska
Journal:  BMC Gastroenterol       Date:  2018-01-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.